文献速递胃肠外科肝胆胰外科

淋巴管生成基因表达与结直肠癌肝转移肝切除术后淋巴结复发及不良预后相关

Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis.
PubMed 文献 · Ann Surg · 2017-01-01

本研究探讨淋巴管生成基因集(VEGFC、Nrp-2等)在结直肠癌原发灶和肝转移中的表达意义,发现该基因集高表达与两者不良预后相关,且肝转移中VEGFC和Nrp-2高表达与肝切除术后淋巴结复发相关,阻断Nrp-2可减少肿瘤细胞穿透淋巴内皮细胞层。

要点

  • 淋巴管生成基因集高表达与结直肠癌原发灶和肝转移灶的不良预后相关。
  • 结直肠癌肝转移切除术后淋巴结复发与VEGFC和Nrp-2高表达相关。
  • 阻断Nrp-2可显著减少Colo320细胞穿透淋巴内皮细胞单层。

核心结论

  • 淋巴管生成基因表达在原发性和转移性结直肠癌中均与更差预后及共识分子亚型4相关。
  • VEGFC和Nrp-2表达可能预测结直肠癌肝转移切除术后复发的淋巴结受累。
  • Nrp-2可能通过介导淋巴管侵犯机制成为结直肠癌的潜在新靶点。

研究设计与样本

  • 设计淋巴管生成基因集(VEGFC、Nrp-2、PDPN、LYVE-1、MRC1、CCL-21),并应用于大型结直肠癌数据集。
  • 在切除的结直肠癌肝转移标本中通过RT-QPCR评估淋巴管生成特征基因表达。
  • 体外实验使用结肠癌细胞系Colo320(高表达Nrp-2)和人真皮微血管淋巴内皮细胞(LECs)。

主要发现

  • 淋巴管生成基因表达在原发性和转移性结直肠癌中均与不良预后相关。
  • 高表达共识分子亚型4标识基因的结直肠癌肝转移也显示高淋巴管生成基因表达。
  • 结直肠癌肝转移切除术后淋巴结复发与VEGFC和Nrp-2高表达相关。
  • 阻断Nrp-2显著减少Colo320细胞通过LEC单层的侵袭。

临床怎么用

  • 检测结直肠癌肝转移标本中VEGFC和Nrp-2表达可能有助于评估术后淋巴结复发风险。
  • Nrp-2可作为结直肠癌淋巴管侵犯的潜在治疗靶点,但需进一步临床验证。

局限性

  • 体外实验仅使用Colo320细胞系和真皮微血管淋巴内皮细胞,结果需体内模型验证。
  • 淋巴管生成基因表达与淋巴结复发的关联基于回顾性标本分析,需前瞻性研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the relevance of lymphangiogenic gene expression in primary and liver metastasis of colorectal cancer (CRC) and identify determinants of lymphatic invasion. BACKGROUND: Lymphatic development promoting vascular endothelial growth factor C (VEGFC) is associated with poor outcome in primary CRC. For colorectal liver metastasis (CRLM), intrahepatic lymph invasion and lymph node metastasis are poor prognostic factors. Exact biological factors promoting lymphatic involvement remain elusive, just as the association with molecular subtypes of CRC. METHODS: We designed a lymphangiogenic gene set (VEGFC, Nrp-2, PDPN, LYVE-1, MRC1, CCL-21) and applied it to large datasets of CRC. Gene expression of the lymphangiogenic signature was assessed in resected CRLM specimens by Rt-QPCR. In vitro experiments were performed with colon cancer cell line Colo320 (high Nrp-2 expression) and human dermal microvascular lymphatic endothelial cells (LECs). RESULTS: Lymphangiogenic gene expression was associated with poor prognosis in both primary and liver metastasis of CRC. CRLM with high expression of consensus molecular subtype-4 identifier genes also exhibited high lymphangiogenic gene expression. Lymph node recurrence following CRLM resection was associated with high expression of VEGFC and Nrp-2. Blocking Nrp-2 significantly reduced invasion of Colo320 cells through an LEC monolayer. CONCLUSIONS: Lymphangiogenic gene expression is correlated with worse prognosis and consensus molecular subtype-4 in both primary and liver metastatic CRC. VEGFC and Nrp-2 expression may be predictive of lymph node involvement in recurrence after resection of CRLM. Nrp-2, expressed on both tumor and LECs, may have a mechanistic role in lymphatic invasion and is a potential novel target in CRC.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Vellinga TT, Kranenburg O, Frenkel N, et al. Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis. Ann Surg. 2017. PMID: 28742689. doi:10.1097/SLA.0000000000002430

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。